Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by CancerSlayer

V.TLT

RE:RE:RE:RE:so tiresome

DJDawg wrote: Great Science! 2 conferences in the last few months! and 0.235...

May 24, 2023

C.COOL

RE:Core One in Talks with Multiple Companies to Supply Psilocyb

lscfa wrote: https://www.accesswire.com/753256/Core-One-in-Talks-with...

May 21, 2023

V.TLT

RE:RE:RE:Hot off the press!

  Good science has no borders...it's recognition of science that...

May 18, 2023

V.TLT

RE:RE:Wild and Crazy Cell Death

Eoganacht wrote: Actually, necrosis is the real wild and crazy cell death...

May 18, 2023

V.TLT

RE:RE:RE:You think?

  I'll take either...point well taken.  Hold onto your shares...

May 17, 2023

V.TLT

RE:You think?

Eoganacht wrote: “We believe Ruvidar has the potential to achieve a better...

May 17, 2023

V.TLT

RE:RE:What's Next?

enriquesuave wrote: Eoganacht wrote: Given the stability of CRs after the...

May 15, 2023

V.TLT

RE:RE:Converting IR to CR

CancerSlayer wrote: Kingpin68 wrote: The last update was about IR's...

May 12, 2023

V.TLT

RE:Converting IR to CR

Kingpin68 wrote: The last update was about IR's that were converted to CR...

May 12, 2023

V.TLT

RE:IBRX Crashes as FDA issues CRL

  Our competition is weakening by the day...either by suboptimal...

May 11, 2023

V.TLT

RE:RE:RE:RE:Applying for Breakthrough seems very close now

enriquesuave wrote: Rumpl3StiltSkin wrote: According to the table 1 from the...

May 10, 2023

V.TLT

RE:RE:Question about AUA Swimmer's Plot

CancerSlayer wrote: Eoganacht wrote: There are a few rows in the AUA...

May 8, 2023

V.TLT

RE:Question about AUA Swimmer's Plot

Eoganacht wrote: There are a few rows in the AUA Swimmer's Plot I don'...

May 8, 2023

V.TLT

RE:Spanish Researchers inspired by success of TLD1433

 Thanks Eoganacht....another great find.   Our trial could be...

May 8, 2023

V.TLT

RE:Li Ka Shing?

  I think a grant from Li Ka Shing & other sources has a better...

May 7, 2023

V.TLT

RE:RE:RE:RE:RE:Updated May 1 2023

  My guess is they get funding independently or via partnership before...

May 7, 2023

V.TLT

RE:RE:RE:Updated May 1 2023

Infinity wrote: Rumpl,  I guess, I missed Virginia which is not...

May 7, 2023

V.TLT

RE:From 2021 but still relevant...

Eoganacht wrote: Quotes from Dr. McFarland:   “TLD-1433 is...

May 6, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:Finances

Rumpl3StiltSkin wrote: I think at this point, given the CR numbers. TLT will...

May 5, 2023

V.TLT

RE:RE:RE:RE:RE:one article - new today

Correction has been highlighted: It looks like they are taking a more...

May 4, 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc

NurExone Biologic Inc V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »